Major depressive disorder (MDD) is the leading cause of disability in the world (WHO). The severe, recurrent form often onsets during childhood or adolescence and becomes chronic. Heritability (35-70%) is similar to that of other common disorders for which genetic methodologies have yielded major discoveries. However, genome-wide association (GWA) studies have not yet produced significant results, and success may require much larger samples than are available. Alternative discovery strategies are urgently needed. Here, we will integrate genome-wide gene expression data from fresh blood with GWAS data to detect expression quantitative trait loci (eQTLs - SNP loci that influence gene expression) with the goal of discovering new MDD susceptibility loci using two novel analytic strategies, including a gene network analysis method that will be substantially developed in the context of this work. We will also seek to refine and confirm the results with genome-wide expression data from brain tissue. We will recruit a new, population-based sample of 500 new recurrent MDD cases and 500 depression-free controls, using a novel strategy in collaboration with a survey research company. Using RNA extracted from RNA-stabilized whole blood, genome-wide gene expression levels will be assayed with Illumina HT-12 array, and common SNP genotypes will be assayed (Illumina 660W) from DNA. (We will also assay brain tissue from two regions from 39 case and 27 control specimens for confirmatory studies.) Potential non-genetic sources of variability will be considered and statistically controlled. Two novel analytic strategies will be used to discover MDD susceptibility alleles, genes and gene regulatory networks. (1) A univariate discovery strategy will identify case-control gene expression differences;detect SNP eQTLs for the selected genes using genome-wide SNP data in controls;and test the association of these SNPs to MDD in two independent GWA datasets. The prior selection of a small number of eQTLs in a separate sample greatly improves power by reducing the burden of multiple testing in GWA analysis. (2) We will extend a novel multivariate method that uses machine learning algorithms to detect gene regulatory networks, and then apply this model to the analysis of the association of co-regulated gene modules to MDD. These algorithms (a) use a background pathway graph that integrates a wide range of high-throughput and curated bioinformatic data to predict biological relationships between genes, to bias the algorithm toward biologically plausible hypotheses;and then (b) use eQTL data to construct a set of gene regulatory modules (co-expressed genes) and infer a sparse regulatory program for each module. The method will then be applied to the GWA data, and (using a novel transfer learning method) to brain data. These studies will identify genes and gene networks underlying susceptibility to major depression.

Public Health Relevance

The proposed project will recruit individuals with and without histories of recurrent depression and then study both the DNA sequence and the activity levels of genes in blood cells. Using a new set of statistical methods, the study will attempt to identify genes and networks of genes that are altered in some people who suffer from depression. This information would be useful in finding new treatment or prevention strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
High Impact Research and Research Infrastructure Programs (RC2)
Project #
5RC2MH089916-02
Application #
7941979
Study Section
Special Emphasis Panel (ZMH1-ERB-C (A4))
Program Officer
Koester, Susan E
Project Start
2009-09-30
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$1,501,832
Indirect Cost
Name
Stanford University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Ho, Kwo Wei David; Han, Shizhong; Nielsen, Jakob V et al. (2018) Genome-wide association study of seasonal affective disorder. Transl Psychiatry 8:190
Giacopuzzi, Edoardo; Gennarelli, Massimo; Sacco, Chiara et al. (2018) Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables. BMC Genomics 19:963
Mullins, N; Power, R A; Fisher, H L et al. (2016) Polygenic interactions with environmental adversity in the aetiology of major depressive disorder. Psychol Med 46:759-70
Peyrot, W J; Lee, S H; Milaneschi, Y et al. (2015) The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects. Mol Psychiatry 20:735-43
Minelli, A; Magri, C; Barbon, A et al. (2015) Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder. Transl Psychiatry 5:e687
Mostafavi, S; Battle, A; Zhu, X et al. (2014) Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry 19:1267-74
Battle, Alexis; Mostafavi, Sara; Zhu, Xiaowei et al. (2014) Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res 24:14-24
Mostafavi, Sara; Battle, Alexis; Zhu, Xiaowei et al. (2013) Normalizing RNA-sequencing data by modeling hidden covariates with prior knowledge. PLoS One 8:e68141
Odgerel, Z; Talati, A; Hamilton, S P et al. (2013) Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health's Collaborative Center for Genomic Studies. Transl Psychiatry 3:e307
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium; Ripke, Stephan; Wray, Naomi R et al. (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18:497-511